Suppr超能文献

苏丹黑热病后皮肤利什曼病的趋势:病例、种族分布及康复情况

Trends in Post-Kala-Azar Dermal Leishmaniasis in Sudan: Cases, Ethnic Distribution, and Recovery.

作者信息

Osman Osama S, Hamid Mohamed E

机构信息

Gadarif Regional Institute of Endemic Diseases, University of Gadarif, Gadarif, Sudan.

Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.

出版信息

Am J Trop Med Hyg. 2025 Mar 18;112(6):1196-1200. doi: 10.4269/ajtmh.24-0602. Print 2025 Jun 4.

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) is a neglected tropical disease that can develop after treatment of leishmaniasis. It causes significant health risks and serves as a reservoir, perpetuating transmission. Current information on PKDL characteristics is crucial for effective disease management and control. This study aimed to describe clinical and epidemiological characteristics of PKDL patients in eastern Sudan. A retrospective cross-sectional study was conducted on suspected PKDL patients (N = 37) at a tertiary hospital in eastern Sudan. Blood samples were tested for anti-rK39 antibodies to confirm the diagnosis of the disease. Demographic, clinical, and epidemiological data of the PKDL patients were gathered and analyzed. Most PKDL cases (69.4%) came from specific locations involving one ethnic group (94.6%), mainly affecting young males (54.1%). A family history of PKDL was noted in only 27.0% of cases; 51.4% developed PKDL within 1 month after visceral leishmaniasis (VL) treatment. Most cases (56.8%) were grade 1 (a low level of parasitic load), predominantly featuring macular (51.4%), papular (18.9%), and nodular (13.5%) lesions. All patients had skin rashes; 91.9% exhibited no fever, and 29.7% reported itching. Lesions appeared within a month after VL treatment, with most patients recovering spontaneously within 3-18 months. PKDL was particularly prevalent in specific regions and ethnic groups, namely the Masaleet and Dago tribes. These findings can enhance PKDL understanding and management in the region.

摘要

黑热病后皮肤利什曼病(PKDL)是一种被忽视的热带疾病,可在利什曼病治疗后发生。它会带来重大健康风险,并作为传染源,使疾病传播持续存在。目前关于PKDL特征的信息对于有效管理和控制该疾病至关重要。本研究旨在描述苏丹东部PKDL患者的临床和流行病学特征。对苏丹东部一家三级医院的疑似PKDL患者(N = 37)进行了一项回顾性横断面研究。检测血样中的抗rK39抗体以确诊该疾病。收集并分析了PKDL患者的人口统计学、临床和流行病学数据。大多数PKDL病例(69.4%)来自涉及一个民族(94.6%)的特定地点,主要影响年轻男性(54.1%)。仅27.0%的病例有PKDL家族史;51.4%在内脏利什曼病(VL)治疗后1个月内出现PKDL。大多数病例(56.8%)为1级(寄生虫载量低),主要表现为斑疹(51.4%)、丘疹(18.9%)和结节(13.5%)病变。所有患者均有皮疹;91.9%无发热,29.7%有瘙痒症状。病变在VL治疗后1个月内出现,大多数患者在3 - 18个月内自发康复。PKDL在特定地区和民族中尤为普遍,即马萨利特部落和达戈部落。这些发现可增进对该地区PKDL的了解和管理。

相似文献

5
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
10
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.

本文引用的文献

1
The potential impact of human visceral leishmaniasis vaccines on population incidence.人体内脏利什曼病疫苗对人群发病率的潜在影响。
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008468. doi: 10.1371/journal.pntd.0008468. eCollection 2020 Jul.
4
Elimination of visceral leishmaniasis on the Indian subcontinent.印度次大陆内脏利什曼病的消除
Lancet Infect Dis. 2016 Dec;16(12):e304-e309. doi: 10.1016/S1473-3099(16)30140-2. Epub 2016 Sep 28.
6
Post kala-azar dermal leishmaniasis: an unresolved mystery.内脏利什曼病后皮肤利什曼病:一个悬而未决的谜。
Trends Parasitol. 2014 Feb;30(2):65-74. doi: 10.1016/j.pt.2013.12.004. Epub 2014 Jan 2.
7
Leishmaniasis: clinical syndromes and treatment.利什曼病:临床综合征与治疗。
QJM. 2014 Jan;107(1):7-14. doi: 10.1093/qjmed/hct116. Epub 2013 Jun 5.
10
The relationship between leishmaniasis and AIDS: the second 10 years.利什曼病与艾滋病的关系:第二个十年
Clin Microbiol Rev. 2008 Apr;21(2):334-59, table of contents. doi: 10.1128/CMR.00061-07.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验